X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ADCOCK INGRAM (S. Africa) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   ADCOCK INGRAM
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
ADCOCK INGRAM
Jun-14
ALEMBIC LTD/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs53399-   
Low Rs29288-   
Sales per share (Unadj.) Rs4.7118.8-  
Earnings per share (Unadj.) Rs8.8-29.9-  
Cash flow per share (Unadj.) Rs9.0-24.8-  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.793.3-  
Shares outstanding (eoy) m267.03168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.72.9 300.6%   
Avg P/E ratio x4.7-11.5 -40.7%  
P/CF ratio (eoy) x4.6-13.9 -32.9%  
Price / Book Value ratio x1.53.7 40.2%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,96258,031 18.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2383,642 6.5%   
Avg. sales/employee Rs ThNM4,671.9-  
Avg. wages/employee Rs ThNM848.4-  
Avg. net profit/employee Rs ThNM-1,177.2-  
INCOME DATA
Net Sales Rs m1,26020,056 6.3%  
Other income Rs m264140 187.8%   
Total revenues Rs m1,52420,197 7.5%   
Gross profit Rs m83-3,476 -2.4%  
Depreciation Rs m61866 7.1%   
Interest Rs m0543 0.1%   
Profit before tax Rs m285-4,744 -6.0%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6296 2.1%   
Profit after tax Rs m2,343-5,054 -46.4%  
Gross profit margin %6.6-17.3 -37.9%  
Effective tax rate %2.1-6.2 -34.3%   
Net profit margin %185.9-25.2 -737.7%  
BALANCE SHEET DATA
Current assets Rs m1,68914,690 11.5%   
Current liabilities Rs m4868,265 5.9%   
Net working cap to sales %95.432.0 297.9%  
Current ratio x3.51.8 195.4%  
Inventory Days Days217111 195.6%  
Debtors Days Days81124 65.4%  
Net fixed assets Rs m1,6248,563 19.0%   
Share capital Rs m53493 573.6%   
"Free" reserves Rs m5,9600-   
Net worth Rs m7,40415,742 47.0%   
Long term debt Rs m1045,532 1.9%   
Total assets Rs m8,01029,738 26.9%  
Interest coverage x950.7-7.7 -12,294.8%   
Debt to equity ratio x00.4 4.0%  
Sales to assets ratio x0.20.7 23.3%   
Return on assets %29.3-15.2 -192.9%  
Return on equity %31.6-32.1 -98.6%  
Return on capital %31.3-19.8 -158.0%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Net fx Rs m-3280-   
CASH FLOW
From Operations Rs m3461,712 20.2%  
From Investments Rs m-48-526 9.1%  
From Financial Activity Rs m-3015,021 -6.0%  
Net Cashflow Rs m-36,207 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.51 Rs / ZAR

Compare ALEMBIC LTD With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC LTD With: PLETHICO PHARMA  LUPIN LTD  FULFORD INDIA  ORCHID PHARMA LTD  SUVEN LIFE  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 16, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS